Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are left deciphering body movements during interviews to guess the future of this company. Hey Midas, what's your take on Yaki's ceiling stares from the 2:30 mark in the video. One was for a good 5 to 10 seconds.
Yaki just looks and moves like a nervous student giving a speech. Not many movements while he was speaking, but once mic was passed on, fidgeting and awkwardness came about. Maybe he was just adjusting what was in his pocket.
Thanks for the finds n3. Would never have thought to search by first name. Guess you were unsuccessful at finding her firm. Please feel free to post your thoughts on their expertise they bring to the board as well.
As for Mark Germain, WellSford is the right one.
So D, yes I agree with your extreme bias statement, but what did I miss? My point is that the first 2 very long term board members who have been gifted nearly a million shares of the stock I invest in, bring Jack to the table. And no offence taken BTW.
One is the wife of the founder of Pluristem. That's 14 years on the board for her. The second, was a Director of a booming real estate company that was around for a few years with the last quarterly revenues of $9 million with a loss of $600 grand.
And his merger and acquisition experience of Stem Cell Innovations and Amphioxus Cell Technologies is just as stellar. They also did a PP where they raised $3.8 million. (The crowd is roaring)
Now for the last 5 years, he has been a "merchant banker" at some unknown bank for obvious reasons. A bank teller at a merchant bank could claim the same glorious statement on their resume no. Or a greeter at the door.
So far, 2 useless, long term board members of the first 2 I looked at.
Do you think these 2 board members bring any sort of positive for this cutting edge, paradigm shifting, soon to be pharma giant. Or are they just token members of past acquaintances, buddies, wife, classmates, etc. Or are they just yes votes for the twins. Sure board members are jokes for most startups. But we are not a startup this far into the game.
I've shown my research. Please enlighten me with any sort of counter points to these 2 clown. And I thought the twins resumes were pathetic. We now have quadruplets.
So the next one, Hava Klemperer Meretzki. Board member since 2003. Pre-dates LMBO. Collected 415,000 shares. Is she the founder of Pluristem, Dr. Shai Meretzki's wife? They wouldn't do that would they? Well she is!!! What does she bring to the table except yes votes for management and bonuses. Along with Dr. Shai's votes if he still owns shares. Another eye opener to me to this joke of a board. No wonder bonuses were voted in EH? Boys club of Israel with a couple of token chicks. First personal relationship found.
Her bio.
Mrs. Hava Klemperer Meretzki, Adv. is a partner in the law firm of Ben-Noun Meretzki in Haifa, Israel. She specializes in civil, trade and labor law and is presently Vice-Chairman for the National Council of the Israel Bar Association. She previously was a Director of the Israel Electric Company. Ms. Meretzki received a Bachelor's Degree in Law from the Hebrew University in 1991, and in 1992, was admitted to the Israel Bar Association.
What is a Bachelor Degree in Law. Admitted to the bar in 1992? Searching the Israeli Bar Association, could not find her in the lawyer search. Try for yourself.
http://www.israelbar.org.il/english_lawyer_list.asp?sent=1
And being the vice chairman of the Israeli Bar Association, you would think her name would come up somewhere when you search her name on the site. Nope!!!
Now searching her law firm Ben-Noun Meretzki brought no luck. Can't find it anywhere. Again, try yourself.
Two for two. But let's not be pissed off with management. Let them keep on doing what they're doing. I told you I will be relentless on these clowns. We are getting too close to year end for me. These clowns need to go ASAP.
Again Zzatt or anyone for that matter, please show me any benefit with having this person on our board. Not trying to single you out but you are one of the most staunchest supporters of management. And you love to poke fun at the realists that are on this board for obvious, justified reasons.
Since it was the Director's of Pluristem's day to feed at the trough, I thought I'd take a look at them. They just got gifted approximately 1% of the company today. I looked into a lot of them briefly, but will have to focus on them one at a time. Many seemed to have spent their life chasing the dream, just like the head twin.
I will have to look into them one at a time, as it is very time consuming and it is late right now. Please feel free to look into and post as truly this board is pathetic just like management. I fully anticipate some connections from the past on these clowns. Will start with Mark Germain, who has been given 570,000 shares of Pluristem for his impressive board representation. He was first on the list, so here goes.
First here's his Bio from Pluristem's website.
Mr. Mark Germain has served as a Director on the Board of Directors since May 17, 2007. For more than the past five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries. He has been involved as a founder, director, Chairman of the Board, and/or investor in over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law. From 1986 to 1991 he served in senior executive capacities, including as president of a public company that was sold in 1991, at which time he entered the biotech field. In addition to being Co-Chairman at Pluristem, Mr. Germain is a director of the following publicly traded companies: Wellford Real Properties, Inc., Stem Cell Innovations, Inc., and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in the biotechnology field.
So let's look at his current list of being a director. In these "public" companies.
Wellford Real Holdings...Someone please find me this company. Only mention of it is in his bio.
Stem Cells Innovations Inc. Again, someone please find anything on this company of late.
Collexis Hildings Inc... Found something on this one at least. The following link says it it all
https://finance.yahoo.com/quote/CLXS?p=CLXS
What in the world could this clown have ever done to earn himself nearly 600,000 sitting on our board for 10 years. This guy collects his yearly shares, big board meeting cash in person or by telephone, while we get squat. Twins get nearly 600,000 yes votes though that's for sure.
Really I am starting to feel ill for the company I have chosen to invest in, not only cash, but the countless time researching them. It is sickening. Then the have some make fun of my DD. Please, any one of you who have questioned my DD. Find one good thing that this new clown has done that justifies being gifted a million bucks in shares, along with a lot of cash for 10 years of "board meetings". Cmon one of you. Just try. Repetitive, whiner, lots of names I got called.
What's your thought on this fella Zzatt. Just the norm for startup biotechs who have been that startup for well over 10 years. Pathetic. Said I will do one but may try to do the next one in line since this is sooooooo disgusting, just like management. Bet you that's why the Chinese deal fell through. They wanted a board seat.
You may be right there EichKing. We haven't closed below $1.40 since Sept 15th. The day before the pump. I think many are discounting the importance of having something significant by the end of the year. The closer we get, the worse it will be. Really don't want to see what happens come the new year if nothing announced.
$2.5 million of the $15 million in equity vanished from the Israeli investors. I'm sure they feel great about their investment. Just like some here were bragging about their $1.60's steal of a deal. Especially the one who doesn't care about the past!!! LMBO But no, the long timers here know nothing and our posts are useless. But a drift back to the low $1's could actually be a blessing in disguise. Don't think these new investors will have the same blind faith attitude and patience in management like some here. They may be able to start a call for change.
And for those who wonder why people's opinions may have changed from the beginning of the year to now, look at the following from their Jan 2017 presentation.
.
-Data readout dose selection studies ARS-H12017
-Contract with U.S government for ARS-H2/2017
-Initiation of pivotal study ARS NHP- H2/2017
-Data read out phase 1 open label HCT-H2/2017
-Preclinical data Fukushima-H1/17
-Preclinical data NYBC H1/2017
One out of six. That's acceptable right? That's what you want from management right? Experience really isn't important right? Huge bonuses in the same year is an industry norm and perfectly justified when you are under a month away from missing 5 of your 6 beginning of the year milestones right? Give us 5 out of 6 and it would probably be a different story. Or the big one that would make a big difference.
What would be so wrong to actually come out and explain the delays in any or all of these. Two of them coming up on 6 months late. Nothing to worry about there. Just normal delays. Ya right. Pathetic management is what we are stuck with unfortunately. Just do a few scripted interviews and speeches and that should shut them up.
Someone once asked a philosophical question. Who's the bigger idiot? The idiot or the one who believes the idiot? Think about it... Go ahead and cut and copy it and try to poke fun. You know it's true. LMBO
And the drip drip drip of our share price might be the reason for the increased negative tone on this board. The lower this goes the worse it would get don't you think. When should others start to complain? Sub $1. It's possible IMO. If we make it to the end of the year with nothing, we will see what happens. Another delay on Japan coming, or cancellation for some made up reason like Chinese deal was?
A jump to $2 or $3 bucks would shut most if not all of us up don't you think. Was there a ton of negativity in the recent run. Not at all. But upon realizing it was just a fake run to get the most from Israeli investors, it truly sucks. To have something that showed promise, then to realize what it was, further aggravates the long timer holders in this stock.
I would love nothing more than to be posting positive things. Unfortunately the twins want to keep shareholders in the dark. We aren't even getting an updated presentation.
I fail to see the relevance of someone changing their tune after yet another disappointing year of the twins. If one is pleased with a stock's potential or were glad that management said 2017 was going to be "our year" after many many years of waiting, they must stick with that feeling even if management fumbles again. Everyone has a right to change their mind, especially when it comes to the twins granting these substantial bonuses to themselves just to rub it in a little.
How that bonus doesn't bother some is what is truly amazing. You think it's fine and normal, so be it. A 4% stake in the company just given away. They don't make enough already. They don't want options anymore as they just expire worthless right.
Then they magically announce quite a number of releases in the late summer run up, then back to crickets right after the raise. Nothing fishy there right. They were well aware that these would be coming. Hence hiring the 3 firms to pump it up so they can get as much as they can from the Israeli investors. At least they managed to milk as much value as they could from them. Like I said before, hopefully they didn't piss off any of the wrong people.
9 releases not including quarterly report from September leading up to the raise. Since then we have gotten an agreement with Souraska Medical, a patent, peer reviewed article, and a rerelease of ARS results. Amazing.
"Our year" is quickly nearing an end. My thoughts were pretty optimistic in the beginning of the year. Half way through, when I realized they were full of it like they have been since day one, I turned quite pessimistic like you all know and complain about. Had a brief head fake late summer when I thought this was finally it, only to see the raise and hope fade away.
So really it's just been another year of missed milestones and big bonuses. We should all just remain happy though. Management is way over their heads and sorry people don't see it from their pitiful resumes alone, let alone the 10 year price decline. They may do it like Blue said, because ARS is in the hands of someone way more competent...the U.S. Government. And that says a lot for the incompetence of Pluristem if the government looks that great.
They're the ones that changed it from our year to theirs. Be pissed at them for us turning like you said.
It is remarkable isn't it Blue. Have their board buddies vote them an almost 5%gift of the company leaving shareholders in the dark as to why. No comparison to other companies when the board gifted them, only the following quarter. Nothing fishy there EH!!!
21 days left until the end of the year. We will see if any of their milestones come by then. If they don't, board will probably gift them another bonus. That's how they roll. Bigger than the last one, now that kaki will have a full year under his belt. Has to be a personal relationship between them. If not more of the Elbit clan.
Never once said the FDA doesn't approve drugs in the U.S. Why would I. Anyone knows this, at least that's what I thought until I read your post. I was talking about how you said the Government/FDA saves every pharma/biotech company? Everybody should now invest in any U.S Pharma company. Got the backing of the Governmen/FDA and they will save them. LMBOx1000. Again this is just too easy!!!
You a newbie to your company. George should look into those resumes a little deeper. Must be using Pluristems human resources manual. It sure must suck not being able to delete your posts like you can and do on other sites. . OPA!!!
This one takes the cake der Allo.
"The Government/FDA Saves Every Single Pharma/Biotech". What does that even mean. LMBO. But ya, I am clueless. Put this quote right up there with Pluristem selling into the market to support price LMBO!!!
Yes you never know with the twins. I keep an eye out on the following link to see if Pluristem becomes a client. So far nothing.
https://agoracom.com/clients
Recently there was a post about Mesoblast and then winning an award I think. Have a look at their management. WHY would anyone not want this for Pluristem???
http://www.mesoblast.com/company/management-team
LMBO EichKing. I don't know what's worse. beliebing the twins or beliebing Allo. Can you actually believe some belieb both!!! What does that say for them.
Yes you are right Allo OPA!!! He marches to the only two that matter...the twins
To bad he can't "invent" shareholder wealth via share price appreciation. That's beyond his scope of "expertise". Only shareholder wealth he has created is for company employees and directors. Declining share pice is all any outsiders have been rewarded with for the last 10 years!!!. But keep beliebing this old dogs skill set will change. 10 years of the same has done jack Jack!!!
It is astonishing isn't it EichKing, why people wouldn't want new, experienced management. Based upon the tone on other boards, this IS gaining traction!!! I've shown Zami's wonderful past and Yaki's is even worse...well at least the same level of horrific, when you think about what they're trying to accomplish now.
Manager for a couple of years at Ernst and Young, then gets a CFO position at Elbit Vision Systems at the same time Zami is made CEO there. That's it that's all for him. Would love to see personal relationships from the 2 of them. Anyone know if Zami has any daughters? Yaki would be around the right age to become his son in law. Not saying he is, just a thought. There's got to be a personal connection between the two of them before they became conjoined. Maybe someone can find a link between them somewhere.
But the defence of them by some on this board is truly laughable. Yes the king clown stumbled upon a great technology. He has zero ability to get to another level. Just like any of his inventions, dreams, anything in the past. But he will do...
And what is up with Japan. Two years since getting the go ahead, and nada, zip, zilch!!! Can't close a damn $11 million deal to get it going. Unbelievable. Still up in the air, and deadline is fast approaching. If this alone does not show the ineptitude of them, nothing will. To continue to see the Japanese fast track on their presentations is embarrassing to say the least. 2 years!!! But don't worry, they're ok. Thank God for the U.S. government. Out of their sorry hands. But shows are what you clowns should focus on.
LMBOx1000 to whoever thinks these guys are anything but that...clowns. Probably their idea to do that high fivin' Happy video that the chosen one loves so much...along with the dwindling beliebers here. Still some staunch holdouts that have never mentioned even a single negative thing about this company. Hmmmmmmmm. You know who you are and why you're here. LMB'ZZO!!!!
Unfortunately you cannot trade market cap. Just shows the dilution that has gone on for all these years. Wouldn't matter to amy of us if their market cap was $10 billion if the price remains here. And besides, none of us have the luxury of being topped up to make up for the dilution like the twins and their 2 million share gift did. Since options DO care about price and they were fed up with them expiring
My bad. I thought this was the video where he mentions male 100% survival. He does say in this one, "all surviving animals fully recovered from ARS". So that 85% of surviving animals, fully recovered. Not 100% of all the treated ones.
It was all male monkeys survived I believe.
Just because you don't care if it a rehashing of a news release or not, could care less.
Just because you don't care that we have inexperienced management at the helm, could care less.
Just because you don't care how they waste money on these useless shows, could care less
Just because you don't care that they gave themselves big bonuses and have nothing of significance to justify it, could care less.
Just because you don't care they've diluted 3 different times this year, could care less.
Just because you think Zami's stellar past business experience is not a "predictor" of price, could care less.
Pretty much any non factual argument that you bring up, could care less.
I do care and that's the difference. Just your "predictor" statement alone is hilarious. Here's one that may sink in for you...NOT. LMBO
Price December 1, 2007...$3.55
Price December 1, 2017...$1.43.
10 years of what...decline. pretty predictable in hindsight, given Zami's experience.
It is a predictor that our share value stinks. I know you don't care about that either. LMBOx1000 it's just too easy!!!
It has nothing to do with the country of origin per se. It just confirms my assumptions of WHO they work for, as that's where the company is located.
The release makes no mention of the word new, so I would not be holding my breath. Sounds like a rehashing of old news. Did they just hire the chosen one from this board? LMBO. Would be nice to see though.
Cmon EichKing it's Zami reliving his glory day. Walking back in the office with a little swagger in his step...I sold 350 first aid kits at this show. Employees would be fist pumping and he'd feel like da man.
On another note, would have rather had Eisenkraft do the presentation. He is a better speaker and his real title alone sounds much better for the audience in attendance.
Had to listen to pocket mans speech once again as the JP stated their survival numbers went from 30 to nearly 100 percent. Reverting back to mouse trials I see. Nobody here think this is misleading to say the least. I guess since the dosing trial wasn't "really" a phased trial, it could still be considered the truth. Sounds much better too. But it is pretty questionable, not that I would expect anything different from our CEO, with no mention of the Co, pocket man.
Anyone who seriously tries to stick up for these guys have to be the most gullible people in the world. The praise for the chosen one poster on this board says it all when it comes to beliebing. These guys are amateurs, who may just luck out in getting something done eventually. Would have been there already with real leadership.
Wow we have 4 more shows this month to release some news. Fingers crossed guys!!! LMBO. At least they've turned frugal now. They're not issuing news releases to announce their travels. Need to save the cash to get to more shows.
I hope so too trust me. Will feel much better once the announce the start of it it's a similar timeframe right now as the announcement of dosing trial to actual start of it. But this has been stated long ago and in their shareholder updates...presentations, for some time. So it's not earth shattering by any means.
Don't forget who said these plans there happy. Based on past timeframes, next year means anywhere from 2 to 5 years. But this may be plausible since it's not them handling the trials.
I find it intriguing that someone claiming to be from the U.S. would post something (nothing to do with Pluristem though) that would not be picked up by any news channel there. Sending people from Ontario for stem cell treatment to U.S. IS big news in Ontario. Ombudsman report just out today. Just confirms my assumptions 100%. You are definitely right Eichman. As am I in knowing specifically who they are. They are from the capital of Ontario, just to narrow it down. OPA!!!
Sorry Allo. Like the last 500 times you have said the "will we get news" whenever there's a show of some kind, didn't happen again. Sigh. LMBO. Glutton for punishment I guess. But keep on trying. You'll get em next time tiger. But maybe investors are realizing the waste and are going to dump on each show date. LMBO.
You seem to forget one very important piece of this puzzle. THE most important piece..who's in charge. They love the shows remember. We got $15 million in the raise!!! Book em Danno!!! You can go to this one...you can go to this one...who wants New York...any takers for Berlin...spouses allowed on this one...did you not hear...we got $15 million!!!! Wooohooooooo!!! LMBO
No old news there EH. We know they love their shows. LMBO. Excellent posts Allo. We love your work. It's so enlightening. LMBO. No valid way to stick up for the chosen ones EH. LMBO Too bad they're not peddling his specialty...first aid That was his career engineering highlight. He fit them in a car.
To each their own. You want the status quo until we get to a point of failure, that would be little too late. Should we wait until we are under a buck again? I don't want to wait until then. There is more to management than just dealing with government. Management of cash is a huge concern. Do the raise, book tons of shows. It's like kids in a candy store. I think we deserve actual stock bonuses this year. I'm sick of options expiring below par. Let's vote it in!!! Done. But now we will have to do a raise so we can continue. Done. Let's postpone the shareholder's year for another. Almost done. Where will it end?
Your suggestions are duly noted, and have thought of some already. Right now I will be looking into a little more of their past when I have a moment. Have a look at the demeanour on other boards. Many are getting fed up. I really think their time is near. So we will see where this takes us.
Can only try no? Our CEO was not able to build a company in his own field. But we should expect him to magically be able to in a new field. We should all just sit back and do nothing and hope for the best. Judging by the crickets here today, I would think that this is finally setting in for some. I was shocked to see what I saw. We were promised this year and by the looks of it, not going to happen. Change needs to happen and the change has to start somewhere. Obviously some of their staunchest supporters will never agree, but I have to question anyone who never has even the remotest of concerns with anything. I give praise where it's due. Unfortunately it doesn't happen too often.
What are your thoughts on what I posted with regards to Zami
LMBOx1000. Using your logic, why would any company ever change CEO's then. Once you're there, should be a job for life since any CEO will do. Was waiting for this predictable post. Truly is amazing. LMBO.
Wow EichKing you make me look like a softie when it comes to the twins. I understand why. Your post made me want to take a look around a little on the experience from the head twin. A little surprised what I found, but I haven't even started looking yet. Just a quick search of the twin and Elbit Vision Systems got me this. I look forward to hearing anyone defend these clowns after reading this. Your turn will come Yaki. I have an extremely long day tomorrow and need to sleep. Thanks Eichking.
Seems like Augusr 21, 2002 he was made CEO of Elbit Vision Systems and on that same day, Yaki was made CFO and Secretary. He was hired by them and they had whopping quarterly earnings of $2.1 million quarterly.
Here's the resume which Elbit bragged about. Notice the unemployed from 1996
https://www.thefreelibrary.com/Elbit+Vision+Systems+Ltd.+--+%60%60EVS%27%27+--+Announces+2002+Second+Quarter+...-a090569692
"Mr Abermann has 15 years of experience in managing industrial companies, international marketing of breakthrough technological solutions to automotive, aerospace, metal industry, and flat panel manufacturing, as well as experience in establishing and managing start-up companies in the software development, chip development, advanced system development, chip development, advanced systems development, flexible automation inspection and image processing. Mr Abermann served as president and CEO of "Robomatix Technologies" from 1987 till 1996. From 1996 Mr. Abermann focused on foundation and management of high tech companies active in various fields."
On a good note, upon looking at what Robomatix does, I found the following. We found some pharma experience...first aid kits. LMBO
Robomatix Technologies Ltd., through its subsidiaries, manufactures, markets, and sells first aid kits primarily to the automotive industry in Germany. The company also engages in the marketing, sale, support, and service of communication equipment, such as switch boards, contact centers, CTI systems, and interactive voice recording systems in Israel. Robomatix Technologies Ltd. markets and sells its first aid kits to retail stores and car manufacturers through distributors and independent agents. The company is based in Tel Aviv, Israel. Robomatix Technologies Ltd. operates as a subsidiary of Tiv Taam Holdings 1 Ltd.
Now he stepped down from Elbit in December 2004. He did his job apparently and Elbit acquired Scanmaster, then let Scanmaster's ex-CEO take over, who was then a director of Elbit. Wow nothing fishy going on there. Great experience though I guess. LMBO.
Zami Aberman has stepped down as president and CEO of Elbit Vision Systems, the Yokneam-based company announced yesterday.
Elbit Vision Systems, whose share is listed on Nasdaq's bulletin board market, was trading down 3.5 percent by midday yesterday.
In its statement to the exchange, Elbit Vision Systems said that Aberman had taken over the company "with the goal of forming and executing a comprehensive turnaround plan. As part of the plan, the company acquired ScanMaster Systems (IRT) in September 2004". Therefore, it noted that Aberman's departure followed "the successful completion of the acquisition of Scanmaster."
The CEO stood down as of Sunday, December 26, and Menashe Shohat, who is currently serving as a director of Elbit Vision Systems, was named the company's new CEO. Shohat, himself, had previously been CEO of ScanMaster, and was instrumental in the successful turnaround of that company, taking it from a long period of losses to profitability in less than two years.
Aberman said yesterday that he had fulfilled his function at Elbit Vision, which is ready to move onto the next phase of development. He acknowledged that he has a new job but refused to divulge what it was.
Elbit Vision, which supplies inspection and quality control systems for, among others, LCDs, FPDs and bare wafers, has gone through an accelerated process of expansion in recent months. In June, it acquired a 51 percent interest in Yuravision of South Korea, which develops inspection systems for liquid crystal display manufacturers. In September, it bought ScanMaster, which develops ultrasonic inspection equipment for the automotive, transportation and metal industries. EVS paid $8 million, of which $3 million was in cash.
Hey Spidey thanks for the reply. Busy is good I hope, as I am as well. Thankfully that will allow me to buy more options as my March ones seem to be coming up faster than ever. Points well taken on all questions.
While zome might think these are invalid questions, I do not. I have always been a fan of the technology, just not management.
Hence the reason for asking about the validity of being called a phase 3 company. The data does look good on all counts, just wasn't sure about the significance of it with such small human numbers. Some good numbers regarding our IC results will put any doubt to ease.
I don't share your optimism on Zami. While yes running a company has similar traits, this complex field they are in is a little different. Connections in the upper levels of management in other big pharma companies would go a long way imo. Just the very name of his "consulting" company says it all. Rose High Tech Ltd.
Having experience would also maybe prevented the missing of targets year after year, and sometimes by years, knowing the complexities and difficulties that can arise in this field.
As for Yaki, see no point in paying him CEO type salary and bonuses. Again, the 2 of them go back a ways, and seems like a complete waste of money to me. Just 2 buddies helping each other out IMO.
And thank you for clarifying the belief that some have that CLI could be approved in 2 weeks to 90 days. Some beliebers out there may have actually believed this. From what I have read, fast track means more frequent meetings with FDA and ability to fill portions of BLA before trial is done, allowing for quicker time frame once trial is over.
Hoping we hear some of these interim results on HCT soon. The study started Feb 8th. All the primary outcome measures have a time frame of a year. So I don't know how they expect to get interim results unless they can before the year has elapsed. Could just be management's projections are exaggerated like usual.
But the estimated completion date is expected to be May 2019. Would have to think they expect all 30 to be enrolled within 5 months. Will be keeping an eye to see if any of these things are changed when they update CT site. It will be a good gauge as well to see how quickly the CLI is progressing as well imo. Even with the "new" person at Pluristem in charge that didn't "drop the ball" like they did in the IC trial like one person here says.
Your previous post on my delay of pivotal ARS trial has given me new hope that maybe this new Bill will get some sort of stock piling contract before approval. Always thoughtthat if they wanted it, they would have gotten this trial started. Your explanation seems reasonable enough for the delay. But you would still think they could announce funding for this trial, in advance of it being ready to go. Then make sure the design of this trial is correct in every way. But like always, we will just have to speculate with any info we find. And of course wait wait wait. The one thing management does best.
Again thank you for your response. A little transparency from management would go a long way. But they've been at this a long time, and don't think that will change ever. They like to keep things under wraps and only the lucky raise participants would get info that us Joe Shmo shareholders could only dream of.
I have looked at the positive and that's why I'm still here. You're complete disregard for the many negatives that make this stock riskier than many here think, is laughable truly. But to each their own. Belieb the eternal optimist who constantly gives false info. LMBO. Just stay in your happy place til we see where it goes/ends. Anyone want to help me find the ignore button. I have a winner for my first one. LMBO Never get my request for intelligent conversations here that's for sure. LMBO Never answers legitimate questions, just writes them all off as nobody knows. LMBO
Hence why I'm asking them to someone who is in the field for their opinion. None of the questions weren't legitimate. To you they were of course, but not to others. Not here for you. LMBO
1. No way. ARS is their biggest near term chance, and would open up other opportunities.
3. $18 million left at the end of last quarter. $23 with $5 in payable. $5.1 million burn per quarter. I think it's higher as I think it was $1.7 million offset as Israeli grant was claimed this quarter.
4. They go to the same shows year after year. Don't think they're invited to that many. Pure waste of time and when your going at a rate they are, a sizeable amount of cash I'm sure.
5. Yes of course we are a "phase 3" company. My point is with our largest trial of 20 people, we are with phase 1 numbers. Phase 2 knocks out a large percentage, then the same with phase 3. Just saying our chances of success are not a given like many think.
6. Don't think any chance until half are enrolled. Late 2019 at earliest IMO
Some questions for Spidey.
Considering you can carry out a civil and thoughtful conversation, I would like to hear your take on some questions I pose to you. Please feel free to answer any or all. That goes for anyone who wants to seriously talk. No problem with anyone who wants to discuss. But you want to name call, I'll tear you a new one. I don't take crap face to face, and definitely won't cower to anonymous posters!!! But intelligent conversations or rebuttals are always welcomed.
1. Do you think having a management team, with little to no experience in this very complex field, is an asset or a hindrance. You obviously have some degree of expertise is this field, so would you rather two people leading the helm that came from Elbit Vision Sytems, or seasoned veterans who are familiar with this complex field. The complications of trial design and such, would have been taken into account when it comes to the pretty much fictitious milestones that the company has missed by years now, if there were experienced management. Would experienced management have given more accurate timeframes?
2. Do you think their bonuses were justified in any which way. Or the Co-CEO role. Any benefits?
3. Is it concerning to you at all, that this company came within 10 months of turning out the lights. Probably 6, before the contingency plan to reduce costs came into play.
4 do you think these shows they spend a lot of money on, bring any benefit to this company, considering the stage we are at?
5. Your feelings on saying we are a phase 3 company, when in essence, our largest combined CLI trial consisted of 20 participants. We have no numbers that constitute a true phase 2 trial. I comprehend that the combining of the phases is the norm now, to speed up the process, but would you still consider us a phase 3 company?
6. Any chance whatsoever, that due to our fast track designation, CLI has any hope to be approved in 2 weeks to 90 days like one poster seems to think?
I look forward to your response for some serious, legitimate discussion. Anyone else care to add.
Correct and didn't think otherwise. Cheers